LivaNova prepares to go live; Corvia raises $17M for heart failure device;

@FierceMedDev: ICYMI: LabCorp, China's Fosun Pharma, lead Asia-heavy $15B investment in Ativa Medical. FierceDiagnostics Item | Follow @FierceMedDev

@VarunSaxena2: Four key medical device recalls of 2015. Feature | Follow @VarunSaxena2

@EmilyWFierce: Human Longevity joins with South African insurer for $250 exome sequencing service. FierceDiagnostics story | Follow @EmilyWFierce

> The Brits have signed off on the merger of Sorin and Cyberonics ($CYBX). It's all slated for the newly resulting LivaNova to be a done deal on Oct. 19. More

> Corvia Medical has gotten a second $17 million tranche to reach $34 million to back first transcatheter device designed to treat diastolic heart failure. SEC filing

> Xenios has raised an undisclosed, 8-figure sum in a financing led by ZFHN for its next-gen lung and heart support devices. More

Biotech News

@FierceBiotech: GlaxoSmithKline's asthma injection heads for EU approval. Story | Follow @FierceBiotech

@JohnCFierce: ICYMI: BIO boots Martin Shkreli's Turing out after pricing controversy erupts. Article | Follow @JohnCFierce

@DamianFierce: Hard to believe but the pope just described biotech valuations as "stretched." | Follow @DamianFierce

> Next-gen oncolytics upstart Replimune grabs a $30M transatlantic venture round. Report

> Concert Pharma's CF drug tops Vertex's top-seller in early study. Story

> GlaxoSmithKline's asthma injection heads for EU approval. Article

Pharma News

@FiercePharma: Mylan leverages marketing savvy, price hikes to make EpiPen a go-to med. More | Follow @FiercePharma

@EricPFierce: We all know about drug recalls but who tops the list for device recalls? FierceMedicalDevices feature | Follow @EricPFierce

> Novartis brings heart, cancer meds to low-income countries for $1 per month. More

> U.S. cancer drug prices up to 3X higher than in Europe: Study. Article

Vaccines News

> IDRI, Wellcome Trust to take tuberculosis jab to PhIIa in South Africa. Story

> Inovio-led team picks up $24M from DARPA to develop Ebola vaccine, treatments. Report

> Serum Institute sets out for dengue fast track. Article

> Scripps Florida nets 4-year, $6M grant from Gates Foundation for HIV vaccine. Story

> Advaxis reports 'encouraging' PhII cervical cancer vaccine data. More

CRO News

> U.K. CRO Venn buys up another contractor. Item

> ShangPharma plots a $60M splash for biologics R&D in China. Story

> German CRO cozies up to Bayer at its Berlin R&D hub. More

> Covance plots a deeper dive into manufacturing. Story

> BioClinica reaches into regulatory affairs with its latest buy. Article

Pharma Manufacturing News

> World's largest reinsurer ready to insure against FDA actions. Report

> Sun Pharma recalls more than 216,000 bottles after label leaches chemical. News

> Aesica plant to get power from biomass plant. More

> Mayne kicks off work on new $65M North Carolina plant. Story

> Pfizer finds buyer for Indian plant set to close this month. Article

Pharma Asia News

> Serum Institute of India throttles back on equity sale. Item

> China-focused RuiYi starts PhI in China on autoimmune candidate RYI-008. News

> HK-listed Lee's Pharmaceutical branches out further with Armetheon deal. More

> Japan's MHLW lines up about 50 candidates for fast-track 'sakigake' process. Story

> Australian subsidies for newer drugs go begging as companies avoid paper chase. Article

Suggested Articles

Battelle received an emergency go-ahead from the FDA over the weekend to deploy its decontamination system for N95 respirator masks.

The limited supply of ventilators is one of the chief concerns facing hospitals as they prepare for more COVID-19 cases.

In one of the longest studies to date in high-risk heart disease, researchers found no significant difference in death rates over more than 10 years.